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Summary: In order to eliminate positive interferences that take place with the Jaffe technique, the Kodak
Ektachem and Boehringer Mannheim Companies have chosen an enzymatic method for the determination
of creatinine in serum and urine. Pathological and clinical samples often contain metabolites in elevated
concentrations or exogenous compounds such as drugs or toxic compounds. We noticed that patients receiving
metamizol-containing drugs showed unusually low values of creatinine when determined with an Ektachem
analyser. We investigated the effect of the main metabolites of this prodrug on the creatinine enzymatic
methods of Kodak and Boehringer. We concluded that methyl-amino-antipyrine, the active substance after
administration of metamizol (prop. INN) was responsible for the interference, and that no reliable determi-
nation of creatinine could be performed with these methods in the serum of patients receiving this drug.
Introduction
Though registration of metamizol (dipyrone) has been
cancelled in some countries (e. g. USA) due to rare
cases of drug-induced agranulocytosis, this drug is a
widely used analgesic in Switzerland and other Eur-
opean countries. The creatinine determinations of pa-
tients receiving "Novalgin®" gave surprisingly low
values with the dry slide enzymatic method of Kodak
Ektachem. This first observation was later confirmed
by Gascon et al. (1). The other enzymatic method
from Boehringer gave similar interferences.
In order to study drug interference in chemical tests,
the in vivo relevant drug and/or metabolites at their
respective concentration after usual dosage are to be
considered.
The metabolism of metamizol has been extensively
studied (2). It has been shown that after iv. or oral
administration of the drug in healthy humans, the
hydrolysed compound, methyl-amino-antipyrine, is
mainly detected. Metamizol can thus be considered
as a prodrug, methyl-amino-antipyrine being the ac-
tive substance. A l g iv. administration of metamizol
in man, rapidly gives the hydrolysis product, methyl-
amino-antipyrine (serum cmax = 57 mg/1) which un-
dergoes either oxidation to formyl-amino-antipyrine
(Cmax = 3 mg/1) or demethylation to amino-antipyrine
(Cmax — 3 mg/1). Amino-antipyrine is further meta-
bolised to acetyl-amino-antipyrine (cmax = 3 mg/1) (3).
Methyl-amino-antipyrine, formyl-amino-antipyrine,
amino-antipyrine and acetyl-amino-antipyrine are
present in the highest concentrations, and represent
more than 70% of all the identified metabolites of"
metamizol in humans (4).
Materials and Methods
Samples and standards
4-Amino-antipyrine (p-amino-phenazone) and antipyrine were
from Fiuka AG (Buchs, Switzerland). Methyl-amino-antipy-
rine, acetyl-amino-antipyrine and formyl-amino-antipyrine
were synthesised by Hoechst and kindly offered for this study.
Portions of 90 μΐ of serum were spiked with 10 μΐ of solutions
containing 500 mg/1 of metamizol, methyl-amino-antipyrine or
antipyrine, and 15 mg/1 of formyl-amino-antipyrine, amino-
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antipyrine or acetyl-amino-antipyrine. Other portions of serum
were spiked with 10 of solutions containing 2 mmol/1 of each
compound. Serum was also spiked with pure water, so that the
dilution procedure was taken into account for comparison
purposes.
All specimens came from hospitalised patients, some with nor-
mal creatinine serum concentrations, other with high concen-
trations due to renal insufficiency.
Crea t in ine de te rmina t ion wi th Ektachem slides
This is our routinely used method. As two types of dry chem-
istry slides have been developed by the Kodak Ektachem Com-
pany, it is important to mention that only the "single slide
methodology" was investigated and used for all experiments.
The different steps of the methodology are represented on figure
1 (5, 6). The method was calibrated according to Kodak's
recommendations using lyophilised calibrators and their "Sup-
plementär}' Assigned Values" (7). The use of supplementary
assigned values during calibration enables the analyser to report
anaiyte concentrations which are as close as possible to the
values that would be obtained with the reference method (this
is "High Performance Liquid Chromatography" (8) in the case
of creatinine). Controls for normal and pathological values
(Kodatrol I and II, Eastman Kodak Company, Rochester, USA)
were run each day, and series were rejected whenever one of
the controls was out of the acceptable range. The analyser used
was an Ektachem 500.
Creat in ine determinat ion with Boehringer ki t
The Boehringer Mannheim kit No. 836 885 was used as another
enzymatic method for comparison. Samples were run on a
Cobas Mira (Hoffmann-La-Roche Ltd, Basel, Switzerland).
Again normal and pathologic controls (Monitrpl, Baxter Dade,
Miami, USA)) were run each day to validate series of creatinine
determinations. The reactions are the same as in the Kodak
method, except that the last step employs a different dye (fig. 1).
Creatinine determination with the Jaffe method
The kinetic Jaffe method without deproteinisation was used to
establish the creatinine concentrations of specimens that were
supplemented with metamizol or metabolites. We used kit No.
0711152 from Roche^ and a Cobas Mira as the analyser. The
same controls from Baxter were usefi on each day.
The concentrations of creatinine determined with these three
methods are different. The spiking of specimens induces a
variation of the sample matrix known to give inaccurate results
with dry slide chemistry. In order to visualise results indepen-
dently of these phenomena, all results are presented as a relative
(per cent) concentration of the water-supplemented specimen.
All determinations were assayed twice. The mean of both results
was used for further calculations. With each method, intra-
assay variations are significantly lower (CV < 3%) than the
interference observed on spiked specimens.
Results
Effect of each metabolite at cmax
Three sera, with a low, medium and high content of
creatinine, were spiked with metamizol and each of
the four main metabolites at their respective cmax.
Creatinine was determined with both enzymatic meth-
ods. Results can be seen in figure 2. It is worth noting
that spiking with metamizol itself, from ä Növalgin®
ampoule, gives the same kind of interference as spik-
ing with methyl-aminp-antipyrine alone. This con-
firms the result of Itoh et al. (9) who showed that
metamizol is rapidly hydrolysed in vitro, as well as in
vivo. Figure 2 shows that after an usual iv. dose of
metamizol, methyl-amino-antipyrine is the only me-
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Fig. 1. Determination of creatinine according to Kodak and Boehringer methodologies (PAP = p-annno-phenazone = 4-amino^
antipyrme = AA; TBHB = 2,4,6-tribromo-3-hydroxybenzoic acid).
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Fig. 2. Influence of metamizol and metabolites at cmax on the enzymatic determination of creatinine in serum with Kodak and
Boehringer methods.
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Fig. 3. Influence at equivalent molar concentration (0.2 mmol/1, equivalent for methyl-amino-antipyrine to 50 mg/1) of metamizol
and metabolites on the enzymatic determination of creatinine in serum with Kodak and Boehringer methods.
tabolite responsible for the decrease of the creatinine
results. The other metabolites do not significantly
interfere but this assay does not indicate whether the
interference is structure related or not.
Effect of metabolites at the same concen-
trations
The cmax value of methyl-amiiio-antipyrine of 50 mg/1
used for the preceding assays corresponds to 0.20
mmol/1; in vitro spiking with an equivalent molar
concentration of metabolite was performed. Though
it is not a natural metabolite of metamizol, antipyrine
was added to these assays in order to enlarge the
structure-related study. Results are found in figure 3.
Here again the only interfering molecule is methyl-
amino-antipyrine. Interference is greater in the Ek-
tachem method than in the Boehringer. As Kodak
Inc. does not communicate its procedure character-
istics, it is difficult to assess if this is due to the
different proportion of enzyme present in each test.
Importance of the interference with methyl-
amino-antipyrine concentration
Different concentrations of methyl-amino-antipyrine
were used to spike three sera, with low, medium and
high concentrations of creatinine (fig. 4). The higher
the concentration of methyl-amino-antipyrine, the
stronger the interference. With the Ektachem slides
the relative decrease of the creatinine results is greater
with low concentrations than with high concentra-
tions. This is not the case with the Boehringer method.
As the enzymes used in both methods have the same
origin, the explanation may be related to the different
procedures rather than to the nature of the interfer-
ence.
Validation on a large series
Fifty samples covering values of creatinine from 20
to 530 μπιοΙ/1 were spiked with methyl-amino-anti-
pyrine to a final concentration of 50 mg/1. Results of
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Fig. 4. Influence of various concentrations of methyl-amino-antipyrine on the determination of creatinine in serum with the (a)
Kodak and (b) Boehringer methods.
methyl-amino-antipyrine-spiked versus water-spiked
sera analysed on the Ektachem 500 are presented in
figure 5. This is a confirmation on a large scale of the
previous results. The shape of the observed curve
shows that low values are more affected by the
methyl-amino-antipyrine interference than medium
and high values. A linear relation is found for these
higher values.
400
•c 300
Q.
Ο
Ε 200
Ε 100-
100 200 300 400 500 600
Creatinine in water-spiked sera [//mol/l]
Fig. 5. Creatinine determination with Ektachem in sera spiked
with methyl-amino-antipyrine and sera spiked with wa-
ter (50 samples; methyl-amino-antipyrine spiking == 50
mg/l). Correlation curve: y = —17.3 + 0.74 χ;τ = 0.99
Discussion
This study demonstrates the importance of consider-
ing the relevant in vivo drug and/or metabolites at
their usual concentrations.
From an analytical point of view we can say that
methyl-amino-antipyrine, the main metabolite of me-
tamizol, causes significant interference with the en-
zymatic determination of creatinine in serum samples.
As other metabolites and analogous compoun rdo
not display such a behaviour at the same concentra-
tion, this interference seems to be strongly related to
the structure of the molecule. Among the four
enzymes1) used in each of the Ektachem and Boeh-
ringer methodologies, three are identical. It is there-
fore difficult to establish which of the three enzymes
is effectively inhibited by methyl-amino-antipyrine.
In order to foresee the same action from similar drugs,
we asked the Dare® database, giving methyl-amino-
antipyrine as the model compound. No proposed
structure included used drugs or metabolites.
The interference of methyl-amino-antipyrine with the
enzymatic determination of creatinine in serum is
clearly clinically relevant in the range of normal and
low pathological serum concentrations. The true value
is underestimated from 25% to 75%. It not only
influences the interpretation of the serum creatinine
per se, but definitely affects the predictive perform-
ance of equations that estimate creatinine clearances.
Based on the elimination of methyl-amino-antipyrine
in normal subjects (3), it seems therefore reasonable
to observe a 3 day stoppage of metamizol treatment
before obtaining a reliable serum creatinine concen-
tration with an enzymatic methodology.
l) Enzymes:
Creatine amidinohydrolase (EC 3.5.3.3)
Creatinine amidohydrolase (EC 3.5.2.10)
Peroxidase (EC 1.11.1.7)
Sarcosine oxidase (EC 1.5.3.1)
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